{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:38:06Z","timestamp":1776872286076,"version":"3.51.2"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ejogrb.2016.10.028","type":"journal-article","created":{"date-parts":[[2016,10,28]],"date-time":"2016-10-28T23:33:45Z","timestamp":1477697625000},"page":"62-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The role of fibroblast growth factor 2 in patients with uterine smooth muscle tumors: an immunohistochemical study"],"prefix":"10.1016","volume":"207","author":[{"given":"Barbara","family":"Bodner-Adler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Mayerhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Czerwenka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Kimberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Koelbl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Bodner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2016.10.028_bib0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cytogfr.2005.01.004","article-title":"Fibroblast growth factor\/fibroblast growth factor receptor system in angiogenesis","volume":"16","author":"Presta","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.ejogrb.2016.10.028_bib0010","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0306-3623(01)00112-4","article-title":"The discovery of angiogenic factors: a historical review","volume":"35","author":"Ribatti","year":"2000","journal-title":"Gen Pharmocol"},{"key":"10.1016\/j.ejogrb.2016.10.028_bib0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/bcr745","article-title":"Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools?","volume":"6","author":"Granato","year":"2004","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ejogrb.2016.10.028_bib0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0169-5002(00)00187-2","article-title":"Increased serum levels of basic fibroblast growth factor in lung cancer patients: relevance to response of therapy and prognosis","volume":"31","author":"Ueno","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejogrb.2016.10.028_bib0025","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1479-5876-9-104","article-title":"Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients","volume":"9","author":"Kilvaer","year":"2011","journal-title":"J Transl Med"},{"issue":"5","key":"10.1016\/j.ejogrb.2016.10.028_bib0030","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/JTO.0b013e31819f2e38","article-title":"Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: coexpression with VEGFR-3 and PDGF-B predicts poor survival","volume":"4","author":"Donnem","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ejogrb.2016.10.028_bib0035","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jss.2006.01.023","article-title":"Angiogenic profile of soft tissue sarcoma based on analysis of circulating factors and microarray gene expression","volume":"135","author":"Yoon","year":"2006","journal-title":"J Surg Res"},{"key":"10.1016\/j.ejogrb.2016.10.028_bib0040","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s004320050319","article-title":"Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in patients with soft-tissue sarcoma","volume":"125","author":"Graeven","year":"1999","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ejogrb.2016.10.028_bib0045","series-title":"Blaustein\u2019s pathology of the female genital tract","first-page":"561","article-title":"Mesenchymal tumors of the uterus","year":"2002"},{"key":"10.1016\/j.ejogrb.2016.10.028_bib0050","series-title":"World Health Organization classification of tumors: pathology and genetics of tumors of the breast and female genital organs","first-page":"236","article-title":"Mesenchymal tumors and related lesions","year":"2003"},{"key":"10.1016\/j.ejogrb.2016.10.028_bib0055","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0046-8177(99)90043-6","article-title":"Angiogenesis in carcinosarcomas of the uterus: differences in microvessel density and expression of vascular endothelial growth factor between the epithelial and mesenchymal elements","volume":"30","author":"Emoto","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejogrb.2016.10.028_bib0060","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ygyno.2004.09.026","article-title":"Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis","volume":"96","author":"Bodner-Adler","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2016.10.028_bib0065","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ygyno.2006.02.023","article-title":"Expression of Thrombospondin 1 (TPS 1) in patients with uterine smooth muscle tumors: an immunhistochemical analysis","volume":"103","author":"Bodner-Adler","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2016.10.028_bib0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ejogrb.2016.10.028_bib0075","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.molmed.2011.01.012","article-title":"Targeting mutant fibroblast gowth factor receptors in cancer","volume":"17","author":"Greulich","year":"2011","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ejogrb.2016.10.028_bib0080","doi-asserted-by":"crossref","first-page":"7683","DOI":"10.1158\/1078-0432.CCR-05-0771","article-title":"Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene","volume":"11","author":"Barclay","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejogrb.2016.10.028_bib0085","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/ar.20934","article-title":"Expression of hepatocyte growth factor and basic fibroblast growth factor as prognostic indicators in gastric cancer","volume":"292","author":"Zhang","year":"2009","journal-title":"Anat Rec"},{"key":"10.1016\/j.ejogrb.2016.10.028_bib0090","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/annonc\/mdh309","article-title":"Circulating angiogenic factor levels correlate with the extent of disease and risk of recurrence in patients with soft tissue sarcoma","volume":"15","author":"Yoon","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejogrb.2016.10.028_bib0095","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1095\/biolreprod53.3.636","article-title":"Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal endometrium","volume":"53","author":"Mangrulkar","year":"1995","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ejogrb.2016.10.028_bib0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.biochi.2005.07.014","article-title":"Fibroblast growth factors (FGF) in human myometrium and uterine leiomyomas in various stages of tumor growth","volume":"88","author":"Wolanska","year":"2006","journal-title":"Biochimie"},{"key":"10.1016\/j.ejogrb.2016.10.028_bib0105","first-page":"141","article-title":"Expression of angiogenic factors and apoptotic factors in leiomyosarcoma and leiomyoma","volume":"8","author":"Hong","year":"2001","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.ejogrb.2016.10.028_bib0110","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1053\/hupa.2001.27113","article-title":"MIB-1(KI-67), p 53, estrogen receptor and progesterone receptor expression in uterine smooth muscle tumors","volume":"32","author":"Mittal","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejogrb.2016.10.028_bib0115","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/00006250-199406000-00023","article-title":"Uterine smooth muscle tumors of uncertain malignat potential","volume":"83","author":"Peters","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2016.10.028_bib0120","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ygyno.2007.05.013","article-title":"A phase II trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis: a gynecologic oncology group study","volume":"106","author":"Mc Meekin","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2016.10.028_bib0125","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/IGC.0b013e31829590dc","article-title":"Uterine leiomyosarcoma: an updated series","volume":"23","author":"Rauh-Hain","year":"2013","journal-title":"Int J Gynecol Cancer"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211516309848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211516309848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:37:49Z","timestamp":1759556269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211516309848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":25,"alternative-id":["S0301211516309848"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2016.10.028","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of fibroblast growth factor 2 in patients with uterine smooth muscle tumors: an immunohistochemical study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2016.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}